Alicija Krasavceva

Ms. Alicija Krasavceva


Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 July 2025 in Acta medica Lituanica
Verified
Journal Article
Open access
PDF file
AKAlicija Krasavceva
Alicija Krasavceva
JJJuozas Jarašūnas
Juozas Jarašūnas
DJDonatas Jocius
Donatas Jocius
RLRomena Laukiene
Romena Laukiene
ZVZydrune Visockiene
Zydrune Visockiene
VBVirgilijus Beiša
Virgilijus Beiša
Background: Adrenal adenomas, often discovered during imaging studies for unrelated conditions, pose diagnostic and therapeutic challenges due to their varying presentations and potential for hormone secretion. While surgical management remains the standard approach for hormonally active adrenal tumors, percutaneous ablation techniques – such as microwave ablation – have emerged as promising alternatives, particularly for patients who are not candidates for surgery.Materials and methods: This report presents a series of clinical cases in which percutaneous microwave ablation was used as an alternative to adrenalectomy. The study focuses on patients with cortisol-producing adrenal adenomas and explores the effectiveness of this minimally invasive procedure in achieving hormonal control and symptom relief.Results: Microwave ablation was successfully performed in all cases without major complications. Clinical follow-up demonstrated improvement in cortisol levels and relief of symptoms related to hypercortisolism. The procedure was well tolerated, offering an alternative therapeutic option for patients unsuitable for adrenalectomy.Conclusions: Percutaneous microwave ablation may serve as a safe and effective treatment option for cortisol-secreting adrenal adenomas in patients with Mild Autonomous Cortisol Secretion and ACTH-independent Cushing Syndrome who are not candidates for surgery. This approach may provide significant symptom relief and hormonal control with minimal invasiveness.